Martin Schwarze – Evolving Lipid Management in the New Decade – Going from the Past to the Future

This session will teach primary providers concepts, treatments, and new drugs to consider when managing and treating patients with high cholesterol.  It will include new and up-to-date treatments to help lower, manage, and control cholesterol in patients. 

Learning Objectives:  
Review mechanism of action of agents.
Discuss the background of inflammation and its role in diseases.
Highlight guidelines and appropriate drugs to use and when.

Accreditation Statements:
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation.

Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this live activity for a maximum of 1 AMA PRA Category 1 Creditä.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Disclosure:
The MAOPS Education Planning Committee has no relevant financial relationships with any organization producing, marketing, reselling, distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.

Grievance Policy:
All grievances should be in writing and should specify the nature of the grievance.  Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee.  All grievances will receive an initial response in writing within 30 days of receipt.  If the participant does not receive a satisfactory response, then they can then submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.